Matthew B. Lehman
Directeur Général chez Koligo Therapeutics Ltd.
Profil
Matthew B.
Lehman is currently the Chief Executive Officer at Koligo Therapeutics, Inc. and the Chief Executive Officer & Executive Director at Koligo Therapeutics Ltd.
He is also a Member of the Association of Clinical Research Professionals and the European Business Association.
Previously, he served as the President, Chief Executive Officer & Director at Callitas Health, Inc. from 2015 to 2016.
He was also the Chief Executive Officer, MD & Executive Director at Immutep Ltd.
from 2013 to 2014.
Additionally, he held the position of Chief Operating Officer at SPRI Clinical Trials-Global LLC.
Mr. Lehman has a graduate degree from The Trustees of Columbia University in The City of New York and an undergraduate degree from the University of Louisville.
Postes actifs de Matthew B. Lehman
Sociétés | Poste | Début |
---|---|---|
European Business Association | Corporate Officer/Principal | 03/01/2011 |
Association of Clinical Research Professionals
Association of Clinical Research Professionals Miscellaneous Commercial ServicesCommercial Services The Association of Clinical Research Professionals is a non-profit organization that provides over 50 online and in-person training programs for individual sale and institutional licensing. The non-profit company is based in Alexandria, VA and was founded by Lynn E. Regina. The company's courses cover good clinical practice (GCP) and specialized topics, including the anatomy of a protocol, hypothesis development, study design, subject safety, and data integrity risk considerations. The company also offers clinical trial insights research, a solution that combines market research capabilities with unprecedented access. With over 13,000 members, the organization represents, supports, and advocates for clinical research professionals. | Corporate Officer/Principal | 03/01/2011 |
Koligo Therapeutics Ltd.
Koligo Therapeutics Ltd. Medical SpecialtiesHealth Technology Koligo Therapeutics Ltd. engages in development and commercialization of cell therapy, three dimensional bio-printed tissue and other regenerative medicine products. The company was founded on June 27, 2018 and is headquartered in Sydney, Australia. | Directeur Général | - |
Koligo Therapeutics, Inc.
Koligo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Koligo Therapeutics, Inc. develops, manufactures and commercializes transformative cell therapies for the treatment of pancreatic diseases. The company is headquartered in New Albany, IN. | Directeur Général | - |
Anciens postes connus de Matthew B. Lehman
Sociétés | Poste | Fin |
---|---|---|
CALLITAS HEALTH INC. | Directeur Général | 15/03/2016 |
IMMUTEP LIMITED | Directeur Général | 09/07/2014 |
SPRI Clinical Trials-Global LLC
SPRI Clinical Trials-Global LLC Miscellaneous Commercial ServicesCommercial Services SPRI Clinical Trials-Global LLC engages in the provision of clinical research solutions. It offers quality assurance, feasibility and site selection, regulatory management, project management, clinical monitoring, and biometrics. The company was founded by Nick Vatakis in 1972 and is headquartered in Pittsboro, NC. | Directeur des opérations | - |
Formation de Matthew B. Lehman
The Trustees of Columbia University in The City of New York | Graduate Degree |
University of Louisville | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
IMMUTEP LIMITED | Health Technology |
CALLITAS HEALTH INC. | Health Technology |
Entreprise privées | 5 |
---|---|
European Business Association | |
Association of Clinical Research Professionals
Association of Clinical Research Professionals Miscellaneous Commercial ServicesCommercial Services The Association of Clinical Research Professionals is a non-profit organization that provides over 50 online and in-person training programs for individual sale and institutional licensing. The non-profit company is based in Alexandria, VA and was founded by Lynn E. Regina. The company's courses cover good clinical practice (GCP) and specialized topics, including the anatomy of a protocol, hypothesis development, study design, subject safety, and data integrity risk considerations. The company also offers clinical trial insights research, a solution that combines market research capabilities with unprecedented access. With over 13,000 members, the organization represents, supports, and advocates for clinical research professionals. | Commercial Services |
Koligo Therapeutics Ltd.
Koligo Therapeutics Ltd. Medical SpecialtiesHealth Technology Koligo Therapeutics Ltd. engages in development and commercialization of cell therapy, three dimensional bio-printed tissue and other regenerative medicine products. The company was founded on June 27, 2018 and is headquartered in Sydney, Australia. | Health Technology |
SPRI Clinical Trials-Global LLC
SPRI Clinical Trials-Global LLC Miscellaneous Commercial ServicesCommercial Services SPRI Clinical Trials-Global LLC engages in the provision of clinical research solutions. It offers quality assurance, feasibility and site selection, regulatory management, project management, clinical monitoring, and biometrics. The company was founded by Nick Vatakis in 1972 and is headquartered in Pittsboro, NC. | Commercial Services |
Koligo Therapeutics, Inc.
Koligo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Koligo Therapeutics, Inc. develops, manufactures and commercializes transformative cell therapies for the treatment of pancreatic diseases. The company is headquartered in New Albany, IN. | Health Technology |